Poor neutralization and rapid decay of antibodies to sars-cov-2 variants in vaccinated dialysis patients

HIGHLIGHTS

• who: Jessica Bassi et al. from the University of Cambridge, Cambridge, United Kingdom, Clinical School, University of New South Wales have published the article: Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients, in the Journal: PLOS ONE of 21/Oct/2021
• what: The authors provide evidence of a poor neutralizing and rapidly decaying antibody response to mRNA-vaccines in the dialysis population, which supports the strategy of prioritizing these patients for an additional boost and other therapeutic strategies. The authors provide evidence that dialysis patients do not . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.